Legend: : Special Mention  : Important : Very Important : Key Development |
| |
 |
Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review.
Ito M, Takata S, Tatsugami M, Wada Y, Imagawa S, Matsumoto Y, Takamura A, Kitamura S, Matsuo T, Tanaka S, Haruma K, Chayama K, J Gastroenterol. 2009;44(5):365-71 |
| |
Eradication therapy for Helicobacter pylori.
N Vakil, F Megraud, Gastroenterology. 2007 Sep:985-1001 |
| |
Host-bacterial interactions in Helicobacter pylori infection.
MR Amieva, EM El-Omar, Gastroenterology. 2008 Jan:306-23 |
 |
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children.
Gatta L, Vakil N, Leandro G, Di Mario F, Vaira D, Am J Gastroenterol. 2009 Dec;104(12):3069-79; quiz 1080 |
| |
Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection.
Fock KM, Katelaris P, Sugano K, Ang TL, Hunt R, Talley NJ, Lam SK, Xiao SD, Tan HJ, Wu CY, Jung HC, Hoang BH, Kachintorn U, Goh KL, Chiba T, Rani AA, Second Asia-Pacific Conference, J Gastroenterol Hepatol. 2009 Oct;24(10):1587-600 |
| |
Guidelines for prevention of NSAID-related ulcer complications.
Lanza FL, Chan FK, Quigley EM, Practice Parameters Committee of the American College of Gastroenterology, Am J Gastroenterol. 2009 Mar;104(3):728-38 |
| |
Carcinogenesis of Helicobacter pylori.
P Correa, J Houghton, Gastroenterology. 2007 Aug:659-72 |
| |
Helicobacter pylori infection and chronic immune thrombocytopenic purpura: long-term results of bacterium eradication and association with bacterium virulence profiles.
G Emilia, M Luppi, P Zucchini, M Morselli, L Potenza, F Forghieri, F Volzone, G Jovic, G Leonardi, A Donelli, G Torelli, Blood. 2007 Dec 1:3833-41 |
| |
Immunology of Helicobacter pylori: insights into the failure of the immune response and perspectives on vaccine studies.
KT Wilson, JE Crabtree, Gastroenterology. 2007 Jul:288-308 |
| |
Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a lar
W Fischbach, ME Goebeler, A Ruskone-Fourmestraux, T Wundisch, A Neubauer, M Raderer, A Savio, EGILS (European Gastro-Intestinal Lymphoma Study) Group, Gut. 2007 Dec:1685-7 |
| |
The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis.
A Zullo, V De Francesco, C Hassan, S Morini, D Vaira, Gut. 2007 Oct:1353-7 |
 |
Association between Helicobacter pylori infection and inflammatory bowel disease: A meta-analysis and systematic review of the literature.
Luther J, Dave M, Higgins PD, Kao JY, Inflamm Bowel Dis. 2009 Sep 16; |
| |
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
Luther J, Higgins PD, Schoenfeld PS, Moayyedi P, Vakil N, Chey WD, Am J Gastroenterol. 2010 Jan;105(1):65-73 |
| |
Review article: Helicobacter pylori-negative duodenal ulcer disease.
Gisbert JP, Calvet X, Aliment Pharmacol Ther. 2009 Oct 15;30(8):791-815 |
| |
Altered gastric corpus expression of tissue inhibitors of metalloproteinases in human and murine Helicobacter infection.
K Bodger, S Ahmed, L Pazmany, DM Pritchard, A Micheal, AL Khan, R Dimaline, GJ Dockray, A Varro, J Clin Pathol. 2008 Jan:72-8 |
| |
Breath tests for gastrointestinal disease: the real deal or just a lot of hot air?
RJ Saad, WD Chey, Gastroenterology. 2007 Dec:1763-6 |
| |
Detection of Helicobacter pylori gastritis by PCR: correlation with inflammation scores and immunohistochemical and CLOtest findings.
J Weiss, TK Tsang, X Meng, H Zhang, E Kilner, E Wang, W Watkin, Am J Clin Pathol. 2008 Jan:89-96 |
| |
Helicobacter pylori gastritis in children is associated with a regulatory T-cell response.
PR Harris, SW Wright, C Serrano, F Riera, I Duarte, J Torres, A Peña, A Rollán, P Viviani, E Guiraldes, JM Schmitz, RG Lorenz, L Novak, LE Smythies, PD Smith, Gastroenterology. 2008 Feb:491-9 |
| |
Helicobacter pylori infection induces candidate stem cell marker Musashi-1 in the human gastric epithelium.
H Murata, S Tsuji, M Tsujii, T Nakamura, HY Fu, H Eguchi, K Asahi, H Okano, S Kawano, N Hayashi, Dig Dis Sci. 2008 Feb:363-9 |
| |
Helicobacter pylori vaccine: from past to future.
K Agarwal, S Agarwal, Mayo Clin Proc. 2008 Feb:169-75 |
| |
Immunochromatographic monoclonal test for detection of Helicobacter pylori antigen in stool is useful in children from high-prevalence developing country.
J Nares-Cisneros, Y Jaramillo-Rodríguez, VA Martínez-Ordaz, VM Velasco-Rodríguez, A Madero, G Mena-Arias, L Manriquez-Covarrubias, Helicobacter. 2007 Aug:354-8 |
| |
Serum and tissue beta-2 microglobulin levels in patients with Helicobacter pylori infection.
H Akay, A Akay, S K&oeig;klu, Dig Dis Sci. 2008 Feb:358-62 |
| |
Meta-analysis: the effect of supplementation with lactoferrin on eradication rates and adverse events during Helicobacter pylori eradication therapy.
Zou J, Dong J, Yu XF, Helicobacter. 2009 Apr;14(2):119-27 |
| |
Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication.
Essa AS, Kramer JR, Graham DY, Treiber G, Helicobacter. 2009 Apr;14(2):109-18 |
| |
Helicobacter pylori infection and iron stores: a systematic review and meta-analysis.
Muhsen K, Cohen D, Helicobacter. 2008 Oct;13(5):323-40 |
| |
Meta-analysis: efficacy of bovine lactoferrin in Helicobacter pylori eradication.
Sachdeva A, Nagpal J, Aliment Pharmacol Ther. 2009 Apr 1;29(7):720-30 |
| |
Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis.
Wang C, Yuan Y, Hunt RH, Am J Gastroenterol. 2009 Feb;104(2):492-500; quiz 491, 501 |
| |
Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
Zhao F, Wang J, Yang Y, Wang X, Shi R, Xu Z, Huang Z, Zhang G, Helicobacter. 2008 Dec;13(6):532-41 |
| |
Systematic review: Helicobacter pylori infection and impaired drug absorption.
Lahner E, Annibale B, Delle Fave G, Aliment Pharmacol Ther. 2009 Feb 15;29(4):379-86 |
| |
Effect of fermented milk-based probiotic preparations on Helicobacter pylori eradication: a systematic review and meta-analysis of randomized-controlled trials.
Sachdeva A, Nagpal J, Eur J Gastroenterol Hepatol. 2009 Jan;21(1):45-53 |
| |
13C-urea breath test values and Helicobacter pylori eradication.
A Zullo, F Perna, C Ricci, C Hassan, A Tampieri, V De Francesco, S Morini, D Vaira, Dig Dis Sci. 2008 Feb:370-4 |
| |
Childhood Helicobacter pylori infection and growth impairment in developing countries: a vicious cycle?
HJ Windle, D Kelleher, JE Crabtree, Pediatrics. 2007 Mar:e754-9 |
| |
Asia-Pacific consensus guidelines on gastric cancer prevention.
F Di Mario, LG Cavallaro, C Scarpignato, J Gastroenterol Hepatol 2008 Mar;23(3):351-65 |
| |
Comparison of biopsy-based methods for the detection of Helicobacter pylori infection.
J Yakoob, S Abid, W Jafri, Z Abbas, M Islam, Z Ahmad, Br J Biomed Sci. 2006:159-62 |
| |
Critical role of Helicobacter pylori in the pattern of gastritis and carditis in residents of an area with high prevalence of gastric cardia cancer.
M Sotoudeh, MH Derakhshan, B Abedi-Ardakani, M Nouraie, A Yazdanbod, SM Tavangar, J Mikaeli, S Merat, R Malekzadeh, Dig Dis Sci. 2008 Jan:27-33 |
| |
Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication.
L Fuccio, ME Minardi, RM Zagari, D Grilli, N Magrini, F Bazzoli, Ann Intern Med. 2007 Oct 16:553-62 |
| |
Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.
JL Tong, ZH Ran, J Shen, CX Zhang, SD Xiao, Aliment Pharmacol Ther. 2007 Jan 15:155-68 |
| |
Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment.
Jafri NS, Hornung CA, Howden CW, Ann Intern Med 2008 Jun 17;148(12):923-31 |
| |
Regulation of IL-18 in Helicobacter pylori infection.
K Yamauchi, IJ Choi, H Lu, H Ogiwara, DY Graham, Y Yamaoka, J Immunol. 2008 Jan 15:1207-16 |
| |
Relationship among oxidative DNA damage, gastric mucosal density and the relevance of cagA, vacA and iceA genotypes of Helicobacter pylori.
MS Ladeira, RC Bueno, BF Dos Santos, CL Pinto, RP Prado, MG Silveira, MA Rodrigues, W Bartchewsky Jr, J Pedrazzoli Jr, ML Ribeiro, DM Salvadori, Dig Dis Sci. 2008 Jan:248-55 |
| |
Seroprevalence of Helicobacter pylori infection in Malaysian children: evidence for ethnic differences in childhood.
CC Boey, KL Goh, WS Lee, N Parasakthi, J Paediatr Child Health. 1999 Apr:151-2 |
| |
Systematic review and meta-analysis: importance of CagA status for successful eradication of Helicobacter pylori infection.
T Suzuki, K Matsuo, A Sawaki, H Ito, K Hirose, K Wakai, S Sato, T Nakamura, K Yamao, R Ueda, K Tajima, Aliment Pharmacol Ther. 2006 Jul 15:273-80 |
| |
Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?
M Gotteland, O Brunser, S Cruchet, Aliment Pharmacol Ther. 2006 Apr 15:1077-86 |
| |
The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis.
S Padol, Y Yuan, M Thabane, IT Padol, RH Hunt, Am J Gastroenterol. 2006 Jul:1467-75 |
| Supplementary evidence: |
| |
Glutathione S-Transferase T1 (GSTT1) Gene Polymorphism and Gastric Cancer Susceptibility: A Meta-Analysis of Epidemiologic Studies.
Chen B, Cao L, Zhou Y, Yang P, Wan HW, Jia GQ, Liu L, Wu XT, Dig Dis Sci. 2009 Dec 4; |
| |
Epidemiological aspects of Helicobacter pylori infection
H Leclerc, Bull Acad Natl Med. 2006 Apr-May:949-62 |
| |
The diagnostic yield of various tests for Helicobacter pylori infection in patients on acid-reducing drugs.
J Yakoob, W Jafri, Z Abbas, S Abid, M Islam, Z Ahmed, Dig Dis Sci. 2008 Jan:95-100 |